- Home
- MYO vs BIOA Comparison
MYO vs BIOA Comparison
Compare MYO & BIOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MYO
- BIOA
- Stock Information
- Founded
- MYO 2004
- BIOA 2015
- Country
- MYO United States
- BIOA United States
- Employees
- MYO N/A
- BIOA N/A
- Industry
- MYO Industrial Specialties
- BIOA Biotechnology: Pharmaceutical Preparations
- Sector
- MYO Health Care
- BIOA Health Care
- Exchange
- MYO Nasdaq
- BIOA Nasdaq
- Market Cap
- MYO 153.0M
- BIOA 167.8M
- IPO Year
- MYO 2017
- BIOA 2024
- Fundamental
- Price
- MYO $2.02
- BIOA $4.53
- Analyst Decision
- MYO Strong Buy
- BIOA Hold
- Analyst Count
- MYO 3
- BIOA 4
- Target Price
- MYO $9.67
- BIOA $5.67
- AVG Volume (30 Days)
- MYO 453.6K
- BIOA 119.8K
- Earning Date
- MYO 08-05-2025
- BIOA 08-15-2025
- Dividend Yield
- MYO N/A
- BIOA N/A
- EPS Growth
- MYO N/A
- BIOA N/A
- EPS
- MYO N/A
- BIOA N/A
- Revenue
- MYO $38,628,624.00
- BIOA $1,451,000.00
- Revenue This Year
- MYO $55.29
- BIOA N/A
- Revenue Next Year
- MYO $27.18
- BIOA N/A
- P/E Ratio
- MYO N/A
- BIOA N/A
- Revenue Growth
- MYO 97.60
- BIOA N/A
- 52 Week Low
- MYO $1.85
- BIOA $2.88
- 52 Week High
- MYO $7.17
- BIOA $26.62
- Technical
- Relative Strength Index (RSI)
- MYO 35.55
- BIOA N/A
- Support Level
- MYO $1.85
- BIOA N/A
- Resistance Level
- MYO $2.20
- BIOA N/A
- Average True Range (ATR)
- MYO 0.14
- BIOA 0.00
- MACD
- MYO 0.05
- BIOA 0.00
- Stochastic Oscillator
- MYO 32.71
- BIOA 0.00
About MYO Myomo Inc.
Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA).
About BIOA BioAge Labs Inc. Common Stock
Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of human aging. Its focus is metabolic disease, one of the greatest healthcare challenges. The pipeline Products of the company are NLRP3 inhibitors, APJ against, and others.